Yohann Schmitt
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
In silico modeling guides identification of novel JAK1 variants associated with immune dysregulation.
Journal: EMBO molecular medicine
Published: April 09, 2025
Loss of WNT2B Results in Epithelial Defects and Predisposes to Gastrointestinal Dysplasia in Humans.
Loss of WNT2B Results in Epithelial Defects and Predisposes to Gastrointestinal Dysplasia in Humans.
Journal: Cellular and molecular gastroenterology and hepatology
Published: July 23, 2024
TARGET: A phase I/II open-label multicenter study to assess safety and efficacy of fexagratinib in patients with relapsed/refractory FGFR fusion-positive glioma.
Journal: Neuro-oncology advances
Published: May 30, 2024
Combined germline and somatic human FADD mutations cause autoimmune lymphoproliferative syndrome.
Journal: The Journal of allergy and clinical immunology
Published: March 23, 2023
A neomorphic mutation in the interferon activation domain of IRF4 causes a dominant primary immunodeficiency.
Journal: The Journal of experimental medicine
Published: July 28, 2022
IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification.
Journal: Neuro-oncology
Published: November 11, 2020
Somatic reversion of pathogenic DOCK8 variants alters lymphocyte differentiation and function to effectively cure DOCK8 deficiency.
Journal: The Journal of clinical investigation
Published: July 21, 2020
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
Journal: Science (New York, N.Y.)
Published: June 22, 2020
Clinical, molecular, and radiomic profile of gliomas with FGFR3-TACC3 fusions.
Journal: Neuro-oncology
Published: May 16, 2020
FGFR1 actionable mutations, molecular specificities, and outcome of adult midline gliomas.
Journal: Neurology
Published: December 09, 2017
Diffuse gliomas with FGFR3-TACC3 fusion have characteristic histopathological and molecular features.
Journal: Brain pathology (Zurich, Switzerland)
Published: July 19, 2017
Last Updated: 09/26/2026